News
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Eli Lilly is tagging along on actress Kym Whitley’s blockbuster summer in a fresh Zepbound partnership with the “Happy ...
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki's ...
12h
DPA International on MSNResearch shows many people who stop weight loss drugs regain weightPatients prescribed drugs to help them lose weight may experience a rebound in weight gain after stopping their prescription, ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there? Here's what to know.
Explore more
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.
Zepbound led to. With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy hitters to compounded varieties, ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...
Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results